Biolinerx Ltd.-Spons ADRBLRX
13F holders, Q4 2025 (December 31)14holders
3new positions
3sold out
1famous investor
$2.84avg. 13F price*
At the end of Q4 2025, 14 institutions reported holding Biolinerx Ltd.-Spons ADR (BLRX) in their 13F filings, unchanged from Q3 2025. 3 opened new positions and 3 sold out. The largest holders were Citadel Advisors ($104K), Rhumbline Advisers ($10K) and Citigroup Inc. ($6K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Biolinerx Ltd.-Spons ADR
- CUSIP
- 09071M304
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $10K |
| Exits | 3 | $155 |
All 13F filers, Q3 2025 → Q4 2025: 30,486 shares bought and 10,435 shares sold, net +20,051 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Citadel Advisors | 0.00% | Add +265.8% | 36,651 | $104K |
| Rhumbline Advisers | 0.00% | Add +9.2% | 3,353 | $10K |
| Citigroup Inc. | 0.00% | New | 2,038 | $6K |
| UBS Group AG | 0.00% | Reduce -69.5% | 1,951 | $5K |
| Wells Fargo & Company | 0.00% | No change | 1,750 | $5K |
| BNP Paribas Financial Markets | 0.00% | New | 1,500 | $4K |
| Nemes Rush Group LLC | 0.00% | No change | 250 | $693 |
| NewEdge Advisors, LLC | 0.00% | No change | 107 | $296 |
| Morgan Stanley | 0.00% | Reduce -98.3% | 100 | $277 |
| Osaic Holdings, Inc. | 0.00% | Add +2500.0% | 26 | $71 |
| Rockefeller Capital Management L.P. | 0.00% | No change | 12 | $33 |
| Bank of America Corp. | 0.00% | Add +400.0% | 10 | $28 |
| Danske Bank A/S | 0.00% | No change | 2 | $6 |
| Banque Cantonale Vaudoise | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is BLRX's weight in each manager's 13F, not the share of Biolinerx Ltd.-Spons ADR the manager owns.